Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

New indications for antidepressants.

Schatzberg AF.

J Clin Psychiatry. 2000;61 Suppl 11:9-17. Review.

2.

Selective serotonin-reuptake inhibitors: an update.

Masand PS, Gupta S.

Harv Rev Psychiatry. 1999 Jul-Aug;7(2):69-84. Review.

PMID:
10471245
3.

Antidepressants: update on new agents and indications.

Ables AZ, Baughman OL 3rd.

Am Fam Physician. 2003 Feb 1;67(3):547-54. Review. Erratum in: Am Fam Physician. 2004 Mar 1;69(5):1049. Am Fam Physician. 2003 May 1;67(9):1874.

4.
5.

[New indications for antidepressive agents. Now also in anxiety disorders and premenstrual syndrome?].

Hochstrasser B.

MMW Fortschr Med. 2000 Dec 7;142(49-50):41-4. Review. German.

PMID:
11190938
6.

Overview of antidepressants currently used to treat anxiety disorders.

Feighner JP.

J Clin Psychiatry. 1999;60 Suppl 22:18-22. Review.

7.

Pharmacotherapy of generalized anxiety disorder.

Davidson JR.

J Clin Psychiatry. 2001;62 Suppl 11:46-50; discussion 51-2. Review.

8.

SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.

Gorman JM, Kent JM.

J Clin Psychiatry. 1999;60 Suppl 4:33-8; discussion 39. Review.

9.

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

CNS Drugs. 2002;16(6):425-34. Review.

PMID:
12027788
10.

Potential indications for the selective serotonin reuptake inhibitors.

Boyer WF.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:5-12. Review.

PMID:
1431022
11.

[Current drug treatment. Effects of antidepressive agents in nervous and stress-related disorders].

Rosenberg R.

Ugeskr Laeger. 2001 Apr 2;163(14):1985-91. Review. Danish.

PMID:
11307357
12.

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.

Bourin M.

Hum Psychopharmacol. 2003 Apr;18(3):185-90. Review.

PMID:
12672169
13.

Paroxetine: an update of its use in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

Drugs. 2002;62(4):655-703. Review. Erratum in: Drugs 2002;62(10):1461.

PMID:
11893234
14.

Mirtazapine: other indications.

Falkai P.

J Clin Psychiatry. 1999;60 Suppl 17:36-40; discussion 46-8. Review.

15.

New uses for antidepressants: social phobia.

Keck PE Jr, McElroy SL.

J Clin Psychiatry. 1997;58 Suppl 14:32-6; discussion 37-8. Review.

PMID:
9418744
16.

Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.

Liebowitz MR, Hollander E, Schneier F, Campeas R, Welkowitz L, Hatterer J, Fallon B.

Acta Psychiatr Scand Suppl. 1990;360:29-34. Review.

PMID:
2248064
17.

The pharmacologic treatment of anxiety disorders: a review of progress.

Ravindran LN, Stein MB.

J Clin Psychiatry. 2010 Jul;71(7):839-54. doi: 10.4088/JCP.10r06218blu. Review.

PMID:
20667290
18.

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

Zohar J, Westenberg HG.

Acta Psychiatr Scand Suppl. 2000;403:39-49. Review.

PMID:
11019934
19.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
20.

Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines.

Hudson JI, Carter WP, Pope HG Jr.

J Clin Psychiatry. 1996;57 Suppl 8:73-9. Review.

PMID:
8698686
Items per page

Supplemental Content

Write to the Help Desk